What is the generic name?

GLYCOPYRROLATE AND FORMOTEROL FUMARATE

What is the Trade Name for GLYCOPYRROLATE AND FORMOTEROL FUMARATE?

BEVESPI AEROSPHERE

What are the Indications for GLYCOPYRROLATE AND FORMOTEROL FUMARATE?

• 1 INDICATIONS AND USAGE BEVESPI AEROSPHERE is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use: BEVESPI AEROSPHERE is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions ( 5.1 , 5.2 )] . BEVESPI AEROSPHERE is a combination of glycopyrrolate, an anticholinergic, and formoterol fumarate, a long-acting beta 2 -adrenergic agonist (LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1 ) Limitations of Use: Not indicated for the relief of acute bronchospasm or for the treatment of asthma. ( 1 , 5.1 , 5.2 )

References: https://open.fda.gov/